President Trump Signs “Phase Three” COVID-19 Stimulus Bill
On March 27, President Trump signed H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). Earlier the same day, the House passed the economic stimulus bill by voice vote, and the Senate passed the bill with a vote of 96-0 the week before. The
Senate Republicans Release “Phase Three” COVID-19 Stimulus Proposal
On March 19, Senate Majority Leader Mitch McConnell (R-KY) released an economic stimulus bill to fight the coronavirus’s fallout, the Coronavirus Aid, Relief, and Economic Security Act. The proposed plan includes four priorities: direct financial help for the American people; relief for small businesses and their employees;
House Passes Families First Coronavirus Response Act
On March 14, the House passed by 363-40, the Families First Coronavirus Response Act to enhance the federal government’s response to the coronavirus outbreak and address the impact of the virus on personal safety and financial security. The legislation expands access to free testing, provides $1 billion in
Hearings/MarkupsSenate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies: “Review of the FY2021 Budget Request for HHS”
Tuesday, February 25, 2020: The Subcommittee on Labor, Health and Human Services, Education, and Related Agencies of the Senate Committee on Appropriations held a hearing to discuss HHS’s budget request for
Twelve Republican Senators Support Grassley-Wyden Drug Pricing Bill
As of Feb. 18, Senate Finance Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden’s (D-OR) bipartisan drug pricing legislation now has 12 Republican senators in support of the plan. Sen. Grassley said he needs support from at least 25 Republican senators to convince Senate Majority
Hearings/MarkupsHouse Education and Labor Committee: “Markup: H.R. 5800, Ban Surprise Billing Act”
Tuesday, February 11, 2020: The House Education and Labor Committee held a markup for:
Find more details on the hearing here.
Why this is important: The committee approved H.R. 5800, 32-13, to end surprise medical
Hearings/MarkupsHouse Committee on Energy and Commerce, Subcommittee on Oversight and Investigation: “Vaping in America: E-Cigarette Manufacturers’ Impact on Public Health”
Wednesday, February 5: The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held a hearing with executives from five e-cigarette manufacturers serving as witnesses. The executives of Juul, Fontem, Japan
Hearings/MarkupsHouse Committee on the Judiciary, Subcommittee on Crime, Terrorism, and Homeland Security: “Fentanyl Analogues: Perspectives on Classwide Scheduling”
Tuesday, January 28, 2020: The Subcommittee on Crime, Terrorism, and Homeland Security on Judiciary held a hearing on the fentanyl crisis, and the wider discussion of prescription drug scheduling practices. Find more details on the hearing
HouseEnergy and Commerce Asks FDA Commissioner for Details on Complex Generic Drugs
On Jan. 17, the House Committee on Energy and Commerce Chairman Frank Pallone (D-NJ), ranking member Greg Walden (R-OR), health subcommittee Chairwoman Anna Eshoo (D-CA) and ranking member Michael Burgess (R-TX) as well as oversight subcommittee Chairwoman Diana DeGette (D-CO) and oversight
Hearings/MarkupsHouse Committee on Energy and Commerce: “A Public Health Emergency: State Efforts to Curb the Opioid Crisis”
Tuesday, January 14, 2020: The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held a hearing on actions taken by states to address the current opioid crisis.
Why this is important: Common themes